Yale School of Medicine: Study Shows Promise of Immunotherapy Treatment for Penile Cancer
August 12, 2023
August 12, 2023
NEW HAVEN, Connecticut, Aug. 12 (TNSres) -- The Yale University School of Medicine issued the following news:
* * *
Researchers assessed the efficacy of immune checkpoint inhibitors by focusing on patients with locally advanced or metastatic penile cancer
* * *
Penile squamous cell carcinoma is a rare form of penile cancer with limited treatment options. An international study led by Yale Cancer Center researchers at Yale School of Medicine fin . . .
* * *
Researchers assessed the efficacy of immune checkpoint inhibitors by focusing on patients with locally advanced or metastatic penile cancer
* * *
Penile squamous cell carcinoma is a rare form of penile cancer with limited treatment options. An international study led by Yale Cancer Center researchers at Yale School of Medicine fin . . .